Jason N. Gorevic - 01 Mar 2024 Form 4 Insider Report for Teladoc Health, Inc. (TDOC)

Reporting relationship: CHIEF EXECUTIVE OFFICER, Director
Issuer ticker: TDOC
Reported as of: 01 Mar 2024
Net transaction value: -$780,308
SEC form: 4
Accepted by SEC: 05 Mar 2024, 16:09:32 UTC
Prior SEC filing: 05 Dec 2023
Next SEC filing: 20 Mar 2024
Source filing: View source filing
Reporting owner signature: /s/ Adam C. Vandervoort, Attorney-in-Fact

Filing notes and source

Key filing fact

Jason N. Gorevic filed Form 4 for Teladoc Health, Inc. (TDOC) on 05 Mar 2024.

Key facts

This page summarizes Jason N. Gorevic's Form 4 filing for Teladoc Health, Inc. (TDOC).
14 reported transactions and 7 derivative rows are listed below.
Accepted by SEC: 05 Mar 2024, 16:09.

Change

Previous filing in this sequence was filed on 05 Dec 2023.
Current net transaction value: -$780,308.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

TDOC transaction

Common Stock

Options Exercise

Transaction value
Shares: +21,130
Change %: +3.5%
Price
Shares after: 622,864
Date: 01 Mar 2024
Ownership: Direct
Footnotes: F1

TDOC transaction

Common Stock

Options Exercise

Transaction value
Shares: +2,915
Change %: +0.47%
Price
Shares after: 625,779
Date: 01 Mar 2024
Ownership: Direct
Footnotes: F1

TDOC transaction

Common Stock

Options Exercise

Transaction value
Shares: +5,782
Change %: +0.92%
Price
Shares after: 631,561
Date: 01 Mar 2024
Ownership: Direct
Footnotes: F1

TDOC transaction

Common Stock

Options Exercise

Transaction value
Shares: +5,615
Change %: +0.89%
Price
Shares after: 637,176
Date: 01 Mar 2024
Ownership: Direct
Footnotes: F2

TDOC transaction

Common Stock

Options Exercise

Transaction value
Shares: +62,004
Change %: +9.7%
Price
Shares after: 699,180
Date: 01 Mar 2024
Ownership: Direct
Footnotes: F2

TDOC transaction

Common Stock

Options Exercise

Transaction value
Shares: +7,648
Change %: +1.1%
Price
Shares after: 706,828
Date: 01 Mar 2024
Ownership: Direct
Footnotes: F2

TDOC transaction

Common Stock

Sale

Transaction value: -$780,308
Shares: -53,755
Change %: -7.6%
Price: $14.52
Shares after: 653,073
Date: 04 Mar 2024
Ownership: Direct
Footnotes: F3

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

TDOC transaction Derivative

Performance Stock Units

Award

Transaction value: $0
Shares: +63,393
Change %
Price: $0.000000
Shares after: 63,393
Date: 01 Mar 2024
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 63,393
Exercise price
Footnotes: F4, F5, F6

TDOC transaction Derivative

Performance Stock Units

Options Exercise

Transaction value: $0
Shares: -21,130
Change %: -33%
Price: $0.000000
Shares after: 42,263
Date: 01 Mar 2024
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 21,130
Exercise price
Footnotes: F1, F7

TDOC transaction Derivative

Performance Stock Units

Options Exercise

Transaction value: $0
Shares: -2,915
Change %: -100%
Price: $0.000000^*
Shares after: 0
Date: 01 Mar 2024
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 2,915
Exercise price
Footnotes: F1, F8

TDOC transaction Derivative

Performance Stock Units

Options Exercise

Transaction value: $0
Shares: -5,782
Change %: -100%
Price: $0.000000^*
Shares after: 0
Date: 01 Mar 2024
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 5,782
Exercise price
Footnotes: F1, F9

TDOC transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value: $0
Shares: -5,615
Change %: -20%
Price: $0.000000
Shares after: 22,460
Date: 01 Mar 2024
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 5,615
Exercise price
Footnotes: F2, F10

TDOC transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value: $0
Shares: -62,004
Change %: -33%
Price: $0.000000
Shares after: 124,008
Date: 01 Mar 2024
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 62,004
Exercise price
Footnotes: F2, F11

TDOC transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value: $0
Shares: -7,648
Change %: -100%
Price: $0.000000^*
Shares after: 0
Date: 01 Mar 2024
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 7,648
Exercise price
Footnotes: F2, F12

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 12 footnotes

Footnote F1

Performance stock units convert to shares of TDOC common stock on a one-for-one basis.

Footnote F2

Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.

Footnote F3

Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance stock unit and restricted stock unit awards.

Footnote F4

Each performance stock unit represents a contingent right to receive one share of TDOC common stock.

Footnote F5

Performance award amount determined based on metrics in respect of the issuer's 2023 financial results.

Footnote F6

The performance stock units vest as to one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter.

Footnote F7

On March 1, 2024, the reporting person earned 63,393 performance stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter.

Footnote F8

On March 2, 2023, the reporting person earned 5,828 performance stock units, vesting in two substantially equal annual installments beginning on March 2, 2023.

Footnote F9

On March 2, 2022, the reporting person earned 17,346 performance stock units, vesting in three substantially equal annual installments beginning on March 2, 2022.

Footnote F10

On March 1, 2022, the reporting person was granted 67,376 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter.

Footnote F11

On March 3, 2023, the reporting person was granted 186,012 restricted stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter.

Footnote F12

On March 2, 2021, the reporting person was granted 22,944 restricted stock units, vesting in three substantially equal annual installments beginning on the first anniversary of the grant date.